Skip to main content
Clinical Trials/NL-OMON36963
NL-OMON36963CompletedNot Applicable

Microdose (intravenous and oral) and oral dose of S 47445 to assess absolute bioavailability, pharmacokinetic parameters and excretion balance of S 47445 in healthy young male volunteers. - 14C-S 47445 microdosing study

Institut de Recherches Internationales Servier I.R.I.S0 sites6 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
6

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • healthy male Caucasian subjects,
  • non-smoking,
  • EM for CYP2D6,
  • 18 - 45 yrs, inclusive,
  • 19.0 * 28.0 kg/m2, inclusive

Exclusion Criteria

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study

Investigators

Sponsor
Institut de Recherches Internationales Servier I.R.I.S

Similar Trials